China Universal Asset Management Company’s Pacira BioSciences PCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$162K	Buy	7,185 +175	+2%	+$3.89K	0.01%	367
2025 Q4	$181K	Sell	7,010 -866	-11%	-$20.6K	0.01%	352
2025 Q3	$203K	Sell	7,876 -1,424	-15%	-$35K	0.02%	335
2025 Q2	$222K	Buy	9,300 +18	+0.2%	+$454	0.02%	301
2025 Q1	$231K	Sell	9,282 -508	-5%	-$12.2K	0.02%	301
2024 Q4	$184K	Buy	9,790 +918	+10%	+$16.1K	0.02%	333
2024 Q3	$134K	Buy	8,872 +3,404	+62%	+$58.2K	0.01%	332
2024 Q2	$156K	Sell	5,468 -3,462	-39%	-$98.5K	0.02%	269
2024 Q1	$261K	Buy	8,930 +3,557	+66%	+$109K	0.03%	259
2023 Q4	$181K	Buy	5,373 +4,188	+353%	+$123K	0.04%	214
2023 Q3	$36.4K	Buy	1,185 +583	+97%	+$21K	0.01%	250
2023 Q2	$24.1K	Sell	602 -21	-3%	-$868	0.01%	252
2023 Q1	$25.4K	Buy	623 +157	+34%	+$6.25K	0.01%	199
2022 Q4	$18K	Buy	466 +37	+9%	+$1.8K	0.01%	182
2022 Q3	$23K	Buy	+429	New	+$23.9K	0.01%	147